Stage IIIB Breast Cancer AJCC v7 Recruiting Phase 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0092287 (Stage IIIB Breast Cancer AJCC v7)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs